Immunogenicity and Safety of a Fractional Booster Dose of IPV Intradermally Versus Full Dose Intramuscularly
Clinical trial NCT00885157 · COMPLETED
Trial details
- NCT number
- NCT00885157
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2009-10-01
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.